Entheon Biomedical Corp. — Proxy Solicitation & Information Statement 2025

Nov 25, 2025

Entheon Biomedical Corp.
720-999 West Broadway Street, Vancouver, BC V5Z 1K5
Telephone: 604-562-3932

NOTICE OF ANNUAL GENERAL MEETING

NOTICE IS HEARBY GIVEN THAT that the Annual General Meeting of the Shareholders of Entheon Biomedical Corp. (hereinafter called the “Company”) will be held at 15th Floor, 1111 West Hastings Street, Vancouver, BC V6E 2J3 on Monday, December 15, 2025, at 10:00 a.m. (Pacific Time) (the “Meeting”) for the following purposes:

1. to receive and consider the financial statements of the Company together with the auditor's report thereon for the financial year ended November 30, 2024;
2. to fix the number of directors at three (3);
3. to elect the directors for the ensuing year;
4. to re-appoint Manning Elliott LLP, Chartered Professional Accountants, as Auditors for the ensuing year and authorizing the directors to fix their remuneration; and
5. to transact such further or other business as may properly come before the Meeting and any adjournments thereof.

The accompanying information circular provides additional information relating to the matters to be dealt with at the Meeting and is deemed to form part of this notice.

The Board of Directors of the Company has by resolution fixed the close of business on November 5, 2025 as the record date for the Meeting, being the date for the determination of the registered holders of common shares of the Company entitled to notice of and to vote at the Meeting and any adjournment(s) thereof.

Completed forms of proxy must be deposited at the office of the Company’s registrar and transfer agent, Endeavor Trust Corporation, 702-777 Hornby Street, Vancouver, BC V6Z 1S4, or by fax to 604-559-8908 not later than forty-eight (48) hours, excluding Saturdays, Sundays and holidays, prior to the time of the Meeting, unless the chairman of the Meeting elects to exercise his discretion to accept proxies received subsequently.

Non-registered shareholders who receive these materials through their broker or other intermediary are requested to follow the instructions for voting provided by their broker or intermediary, which may include the completion and delivery of a voting instruction form.

DATED this 13th day of November, 2025.

BY THE ORDER OF THE BOARD OF DIRECTORS OF ENTHEON BIOMEDICAL CORP.

(Signed) “Timothy Ko”

Timothy Ko
President, Chief Executive Officer and Corporate Secretary